scholarly article | Q13442814 |
P356 | DOI | 10.1111/JPI.12142 |
P698 | PubMed publication ID | 24786921 |
P50 | author | Francesca Bonomini | Q42532382 |
Gaia Favero | Q42868564 | ||
Michele Samaja | Q45547992 | ||
Laura Terraneo | Q46734554 | ||
Rita Paroni | Q57013200 | ||
P2093 | author name string | Russel J Reiter | |
Rita Rezzani | |||
Paola Bianciardi | |||
Franco Fraschini | |||
Eleonora Virgili | |||
Elena Finati | |||
P2860 | cites work | Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance | Q43680908 |
P433 | issue | 1 | |
P921 | main subject | hypoxia | Q105688 |
melatonin | Q180912 | ||
prostate cancer | Q181257 | ||
P304 | page(s) | 43-52 | |
P577 | publication date | 2014-05-20 | |
P1433 | published in | Journal of Pineal Research | Q15056565 |
P1476 | title | Antitumour activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signalling | |
P478 | volume | 57 |
Q28394036 | Brain adaptation to hypoxia and hyperoxia in mice |
Q33762681 | Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. |
Q35923927 | Heat shock protein 27 downstream of P38-PI3K/Akt signaling antagonizes melatonin-induced apoptosis of SGC-7901 gastric cancer cells |
Q35947279 | Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. |
Q42289972 | Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients |
Q99565353 | Melatonin and urological cancers: a new therapeutic approach |
Q26751220 | Melatonin as a potential anticarcinogen for non-small-cell lung cancer |
Q37108056 | Melatonin downregulates nuclear receptor RZR/RORγ expression causing growth-inhibitory and anti-angiogenesis activity in human gastric cancer cells in vitro and in vivo |
Q33889427 | Melatonin for the prevention and treatment of cancer |
Q30410662 | Melatonin suppresses hypoxia-induced migration of HUVECs via inhibition of ERK/Rac1 activation |
Q33624824 | Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis |
Q58587207 | Melatonin: An Anti-Tumor Agent in Hormone-Dependent Cancers |
Q91668966 | Melatonin: an anti-tumor agent for osteosarcoma |
Q58554204 | Promising Antineoplastic Actions of Melatonin |
Q28077467 | WOMEN IN CANCER THEMATIC REVIEW: Circadian rhythmicity and the influence of 'clock' genes on prostate cancer |
Search more.